Pancreatic Cancer

Earlier Use on Horizon for Novel Agents in Pancreatic Cancer

May 17, 2016

Clinical Articles

With the wealth of data demonstrating efficacy in the metastatic setting, researchers are now assessing nab-paclitaxel/gemcitabine as both an adjuvant and neoadjuvant treatment for patients with pancreatic cancer.